Galera Therapeutics Inc.
Galera Therapeutics Inc. develops small‑molecule SOD mimetics to boost radiotherapy efficacy, with Phase II/III assets for head‑and‑neck cancer mucositis and breast cancer radiosensitization.
Headquarters: United States (USA)
- Website: Visit Site 🔗
- Type: Corporation
Company Profile
- Sector: Professional Services
- Industry: Biotechnology Research
- Employees: 3
- HQ: Malvern
Unlock the full potential.
Upgrade
Get access to Relative P/E Ratio Valuation Histogram.